Toxicity of lead: A review with recent updates.
Flora G, Gupta D, Tiwari A. · 2012
Read Toxicity of lead: A review with recent updates. by Flora G, Gupta D, Tiwari A. (2012) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3485653.txt.
Introduction
Lead harms blood, kidneys, reproduction, and the brain, and Gagan Flora, Deepesh Gupta, and Archana Tiwari review the damage and defenses in this 2012 update. Their survey covers how lead exposure happens, the biomarkers that reveal it, and the role of oxidative stress, damage from reactive oxygen, in most of its effects.
Treatments that protect sulfur-based cell defenses show promise in lab studies. N-acetylcysteine, alpha-lipoic acid, vitamin E, quercetin, and some herbal extracts guard against much lead injury in cells and animals. The review also covers classic chelation therapy, which binds lead for removal, and newer ideas such as nanoencapsulation, packaging drugs in tiny carriers. Cases still occur despite control measures, especially in developing countries.
Catalog record
| CREATOR | Flora G, Gupta D, Tiwari A. |
|---|---|
| YEAR | 2012 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 61 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Toxicity of lead: A review with recent updates By Gagan Flora, Deepesh Gupta, Archana Tiwari Published in: Interdisciplinary Toxicology DOI: 10.2478/v10102-012-0009-2 ABSTRACT Lead poisoning has been recognized as a major public health risk, particularly in developing countries. Though various occupational and public health measures have been undertaken in order to control lead exposure, cases of lead poisoning are still reported. Exposure to lead produces various deleterious effects on the hematopoietic, renal, reproductive and central nervous system, mainly through increased oxidative stress. These alterations play a prominent role in disease manifestations. Modulation of cellular thiols for protection against reactive oxygen species (ROS) has been used as a therapeutic strategy against lead poisoning. N-acetylcysteine, α-lipoic acid, vitamin E, quercetin and a few herbal extracts show prophylaxis against the majority of lead mediated injury in both in vitro and in vivo studies. This review provides a comprehensive account of recent updates describing health effects of lead exposure, relevant biomarkers and mechanisms involved in lead toxicity. It also updates the readers about recent advances in chelation therapy and newer therapeutic strategies, like nanoencapsulation, to treat lead induced toxic manifestations. LIST OF ABBREVIATIONSPbLeadROSReactive oxygen speciesGSHGlutathioneGSSGglutathione disulfideALADδ-aminolevulinic acid dehydrataseALASδ-aminolevulinic acid synthetaseZPPzinc protoporphyrinGPxglutathione peroxidaseCATCatalaseSODSuperoxide dismutaseDMSA2,3-dimercaptosuccinic acidMiADMSAMonoisoamy dimercaptosuccinic acidBBBBlood-brain barrierPPRPaired-Pulse ReactionsEPSPExcitatory postsynaptic potentialPSPopulation spike INTRODUCTION Lead (Pb) is ubiquitous and one of the earliest metals discovered by the human race. Unique properties of lead, like softness, high malleability, ductility, low melting point and resistance to corrosion, have resulted in its widespread usage in different industries like automobiles, paint, ceramics, plastics, etc. This in turn has led to a manifold rise in the occurrence of free lead in biological systems and the inert environment. Lead is regarded as a potent occupational toxin and its toxicological manifestations are well known. The non biodegradable nature of lead is the prime reason for its prolonged persistence in the environment. Human exposure to lead occurs through various sources like leaded gasoline, industrial processes such as lead smelting and coal combustion, lead-based paints, lead containing pipes or lead-based solder in water supply systems, battery recycling, grids and bearings, etc. Although lead toxicity is a highly explored and comprehensively published topic, complete control and prevention over lead exposure is still far from being achieved. There is no such level of lead that appears to be necessary or beneficial to the body and no “safe” level of exposure to lead has been found. Lead toxicity is a particularly insidious hazard with the potential of causing irreversible health effects. It is known to interfere with a number of body functions and it is primarily affecting the central nervous, hematopoietic, hepatic and renal system producing serious disorders (Kalia & Flora, 2005). Acute toxicity is related to occupational exposure and is quite uncommon. Chronic toxicity on the other hand is much more common and occurs at blood lead levels of about 40–60 ug/dL. It can be much more severe if not treated in time and is characterized by persistent vomiting, encephalopathy, lethargy, delirium, convulsions and coma (Flora et al., 2006; Pearce, 2007). EFFECT ON THE NERVOUS SYSTEM Compared to other organ systems, the nervous system appears to be the most sensitive and chief target for lead induced toxicity (Cory-Slechta, 1996). Both the central nervous system and the peripheral nervous system become affected on lead exposure. The effects on the peripheral nervous system are more pronounced in adults while the central nervous system is more prominently affected in children (Brent, 2006; Bellinger, 2004). Encephalopathy (a progressive degeneration of certain parts of the brain) is a direct consequence of lead exposure and the major symptoms include dullness, irritability, poor attention span, headache, muscular tremor, loss of memory and hallucinations. More severe manifestations occur at very high exposures and include delirium, lack of coordination, convulsions, paralysis, coma and ataxia (Flora et al., 2006). Fetuses and young children are especially vulnerable to the neurological effects of lead as the developing nervous system absorbs a higher fraction of lead. The proportion of systemically circulating lead gaining access to the brain of children is significantly higher as compared to adults (Needleman et al., 2004). Children may appear inattentive, hyperactive and irritable even at low lead exposure. Children with greater lead levels may be affected with delayed growth, decreased intelligence, short-term memory and hearing loss. At higher levels, lead can cause permanent brain damage and even death (Cleveland et al., 2008). There is evidence suggesting that low level lead exposure significantly affects IQs along with behavior, concentration ability and attentiveness of the child. Repercussions of lead exposure on the peripheral nervous system have also been observed in the form of peripheral neuropathy, involving reduced motor activity due to loss of myelin sheath which insulates the nerves, thus seriously impairing the transduction of nerve impulses, causing muscular weakness, especially of the exterior muscles, fatigue and lack of muscular co-ordination (Sanders et al., 2009). EFFECT ON THE HEMATOPOIETIC SYSTEM Lead directly affects the hematopoietic system through restraining the synthesis of hemoglobin by inhibiting various key enzymes involved in the heme synthesis pathway. It also reduces the life span of circulating erythrocytes by increasing the fragility of cell membranes. The combined aftermath of these two processes leads to anemia (Guidotti et al., 2008; Cornelis., 2005). Anemia caused on account of lead poisoning can be of two types: hemolytic anemia, which is associated with acute high-level lead exposure, and frank anemia, which is caused only when the blood lead level is significantly elevated for prolonged periods (Vij, 2009). [Table: Types of lead poisoning.] Lead significantly affects the heme synthesis pathway in a dose dependent manner by downregulating three key enzymes involved in the synthesis of heme. δ-aminolevulinic acid dehydratase (ALAD), a cytosolic enzyme that catalyzes the formation of porphobilinogen from δ-aminolevulinic acid (ALA), aminolevulinic acid synthetase (ALAS), a mitochondrial enzyme that catalyzes the formation of aminolevulinic acid (ALA), and finally, the mitochondrial enzyme ferrochelatase that catalyzes the insertion of iron into protoporphyrin to form heme (Piomelli, 2002). The initial and final steps of heme synthesis take place in the mitochondria, whereas the intermediate steps take place in the cytoplasm. Lead inhibits the three aforementioned vital enzymes of this pathway but its effect on ALAD is more profound and its inhibition has been used clinically to gauge the degree of lead poisoning. Inhibition of ALAD results in the accumulation of aminolevulinic acid, detectable in the plasma and urine even at blood lead levels of less than 10 µg/dl. Although ALAD inhibition is first noted at blood lead levels of 10–20 µg/dl, heme biosynthesis does not decrease until the activity of ALAD is inhibited by 80–90%, which occurs at a much higher blood lead concentration of about 55 µg/dl (Ahamed et al., 2005). Inhibition of ferrochelatase results in increased excretion of coproporphyrin in urine and accumulation of protoporphyrin in erythrocytes (EP). Moreover, inhibition of this enzyme results in the substitution of iron by zinc in the porphyrin ring forming zinc protoporphyrin (ZPP). The concentration of ZPP thus gets increased, which can also be used as an indicator to monitor the level of lead exposure (Jangid et al., 2012). Thus, the collective inhibition of these three key enzymes blocks the heme production via the heme synthesis pathway. The mechanism responsible for shortening the